Loading...
HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies
BACKGROUND: Although amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) is used as an indicator for response to trastuzumab, the reported response rate is low, and few patients with gastric cancer (GC) benefit from this individualized therapy. The aim of this study wa...
Na minha lista:
| Udgivet i: | J Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596543/ https://ncbi.nlm.nih.gov/pubmed/33144857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8860174 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|